New Drug Update 2010-2011 Faculty Disclaimer - CME Conferences

More documents

Recommendations

Info

2 nd Annual Essentials in Primary Care Fall Conference Friday, November 11, 2011 American Diabetes Association ADA/EASD Guidelines 2008 Update (Diabetes Care 2009; 32:193–203) Avoid Use of Glyburide? In-hospital mortality in patients on sulfonylureas before admission (n = 459) according to the type of sulfonylureas and stratified by specific subgroups (J Clin Endocrinol Metab, November 2010, 95(11):4993–5002) Wayne Weart New Drug Update Part I
2 nd Annual Essentials in Primary Care Fall Conference Friday, November 11, 2011 Proposed Recommendations for Use of Metformin Based on e-GFR Diabetes Care 2011;34:1435 eGFR (ml/min per 1.73m2) Action >60 No renal contraindication to metformin >45 Continue use Increase monitoring of renal function (every 3–6 months) 30 Prescribe metformin with caution Use lower dose (e.g., 50%, or half-maximal dose) Closely monitor renal function (every 3-6 months) Do not start new patients on metformin
Page 1 and 2: 2 nd Annual Essentials in Primary C
Page 13: 2 nd Annual Essentials in Primary C
Page 65 and 66:
2 nd Annual Essentials in Primary C
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77:
show all

New Drug Update 2010-2011 Faculty Disclaimer - CME Conferences

Create successful ePaper yourself

Delete template?

Save as template?